Skip to main content
. Author manuscript; available in PMC: 2013 Feb 15.
Published in final edited form as: Clin Cancer Res. 2012 Jan 6;18(4):1167–1176. doi: 10.1158/1078-0432.CCR-11-2109

Table 2.

Spectrum of driver oncogene mutations in 95 squamous cell carcinomas.

Gene N (%) with mutation 95% confidence intervals
EGFR 0 0 – 3.8%
KRAS 0 0 – 3.8%
PIK3CA 4 (4.2%) 1.2 – 10.4%
AKT1 1 (1.1%) 0 – 5.7%
BRAF 0 0 – 3.8%
NRAS 0 0 – 3.8%
ERBB2/HER2 0 0 – 3.8%
MAP2K1/MEK1 0 0 – 3.8%
Any mutation 5 (5.3%) 1.7 – 11.9%